menu
    • menu

    Company profile for SciTech

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SciTech is a clinical stage, biopharmaceutical company that has developed a proprietary nano-delivery system (SciTech Delivery Vehicle - SDV) to enable intravenous (IV) delivery of water-insoluble drugs. One such challenged drug is fenretinide, our lead API, has been shown in numerous clinical trials to be a safe and effective anticancer therapy with targeted cancer destroying activity. The patented combination of the new SDV ...
    SciTech is a clinical stage, biopharmaceutical company that has developed a proprietary nano-delivery system (SciTech Delivery Vehicle - SDV) to enable intravenous (IV) delivery of water-insoluble drugs. One such challenged drug is fenretinide, our lead API, has been shown in numerous clinical trials to be a safe and effective anticancer therapy with targeted cancer destroying activity. The patented combination of the new SDV and fenretinide has led to SciTech’s first drug product, ST-001 nanoFenretinide, that holds the promise of improving and saving many lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SciTechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    281 Kercheval Avenue Grosse Pointe Farms, MI 48236
    Telephone
    Telephone
    (313) 938-5517
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.scitechdevelopment.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scitechdevelopment/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ACG Wins Red Dot Design Award For Personalised Medicine Concept
    ACG Wins Red Dot Design Award For Personalised Medicine Concept

    07 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-07/acg-wins-red-dot-design-award-for-personalised-medicine-concept

    PHARMIWEB
    07 Nov 2025
    Share Share
    Scitec Development Closes $5.5M Funding For Cancer Trials
    Scitec Development Closes $5.5M Funding For Cancer Trials

    24 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scitech-development-announces-the-closing-of-oversubscribed-5-5-million-funding-round-to-continue-cancer-clinical-trials-302564946.html

    PR NEWSWIRE
    24 Sep 2025
    Share Share
    SciTech Development Announces First Patient Dosed in Phase 1 Trial of ST-001
    SciTech Development Announces First Patient Dosed in Phase 1 Trial of ST-001

    20 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scitech-development-announces-first-patient-dosed-in-phase-1-clinical-trial-of-st-001-302019518.html

    PR NEWSWIRE
    20 Dec 2023
    Share Share
    SciTech Development Announces Activation of First Three Clinical Trial Sites
    SciTech Development Announces Activation of First Three Clinical Trial Sites

    07 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scitech-development-announces-activation-of-first-three-clinical-trial-sites-for-its-lead-drug-candidate-st-001-301980100.html

    PR NEWSWIRE
    07 Nov 2023
    Share Share
    SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001
    SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001

    03 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scitech-readies-for-first-in-human-trial-with-clinical-supply-of-st-001-nanofenretinide-301946360.html

    PR NEWSWIRE
    03 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search